{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:23:33Z","timestamp":1794831813675,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parallel to major changes in fatty acid and glucose metabolism, defect in branched-chain amino acid (BCAA) catabolism has also been recognized as a metabolic hallmark and potential therapeutic target for heart failure. However, BCAA catabolic enzymes are ubiquitously expressed in all cell types and a systemic BCAA catabolic defect is also manifested in metabolic disorder associated with obesity and diabetes. Therefore, it remains to be determined the cell-autonomous impact of BCAA catabolic defect in cardiomyocytes in intact hearts independent from its potential global effects. In this study, we developed two mouse models. One is cardiomyocyte and temporal-specific inactivation of the E1\u03b1 subunit (\n                    <jats:italic>BCKDHA-cKO<\/jats:italic>\n                    ) of the branched-chain \u03b1-ketoacid dehydrogenase (BCKDH) complex, which blocks BCAA catabolism. Another model is cardiomyocyte specific inactivation of the BCKDH kinase (\n                    <jats:italic>BCKDK-cKO<\/jats:italic>\n                    ), which promotes BCAA catabolism by constitutively activating BCKDH activity in adult cardiomyocytes. Functional and molecular characterizations showed E1\u03b1 inactivation in cardiomyocytes was sufficient to induce loss of cardiac function, systolic chamber dilation and pathological transcriptome reprogramming. On the other hand, inactivation of BCKDK in intact heart does not have an impact on baseline cardiac function or cardiac dysfunction under pressure overload. Our results for the first time established the cardiomyocyte cell autonomous role of BCAA catabolism in cardiac physiology. These mouse lines will serve as valuable model systems to investigate the underlying mechanisms of BCAA catabolic defect induced heart failure and to provide potential insights for BCAA targeted therapy.\n                  <\/jats:p>","DOI":"10.1038\/s41401-023-01076-9","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T03:12:59Z","timestamp":1680059579000},"page":"1380-1390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cell-autonomous effect of cardiomyocyte branched-chain amino acid catabolism in heart failure in mice"],"prefix":"10.1038","volume":"44","author":[{"given":"Jia-yu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph D.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ro-Po","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J. Roth","family":"Flach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yea-Lyn","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"1076_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","volume":"81","author":"M Neinast","year":"2019","unstructured":"Neinast M, Murashige D, Arany Z. Branched chain amino acids. Annu Rev Physiol. 2019;81:139\u201364.","journal-title":"Annu Rev Physiol"},{"key":"1076_CR2","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/JCI38151","volume":"119","author":"G Lu","year":"2009","unstructured":"Lu G, Sun H, She P, Youn JY, Warburton S, Ping P, et al. Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest. 2009;119:1678\u201387.","journal-title":"J Clin Invest"},{"key":"1076_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","volume":"29","author":"MD Neinast","year":"2019","unstructured":"Neinast MD, Jang C, Hui S, Murashige DS, Chu Q, Morscher RJ, et al. Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab. 2019;29:417\u201329.","journal-title":"Cell Metab"},{"key":"1076_CR4","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","volume":"133","author":"H Sun","year":"2016","unstructured":"Sun H, Olson KC, Gao C, Prosdocimo DA, Zhou M, Wang Z, et al. Catabolic defect of branched-chain amino acids promotes heart failure. Circulation. 2016;133:2038\u201349.","journal-title":"Circulation"},{"key":"1076_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/1753-0407.12645","volume":"10","author":"Z Bloomgarden","year":"2018","unstructured":"Bloomgarden Z. Diabetes and branched-chain amino acids: What is the link? J Diabetes. 2018;10:350\u20132.","journal-title":"J Diabetes"},{"key":"1076_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00246-010-9856-9","volume":"32","author":"H Sun","year":"2011","unstructured":"Sun H, Lu G, Ren S, Chen J, Wang Y. Catabolism of branched-chain amino acids in heart failure: insights from genetic models. Pediatr Cardiol. 2011;32:305\u201310.","journal-title":"Pediatr Cardiol"},{"key":"1076_CR7","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.bbadis.2016.09.009","volume":"1862","author":"H Sun","year":"2016","unstructured":"Sun H, Wang Y. Branched chain amino acid metabolic reprogramming in heart failure. Biochim Biophys Acta. 2016;1862:2270\u20135.","journal-title":"Biochim Biophys Acta"},{"key":"1076_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clnu.2015.02.004","volume":"35","author":"JA Pineda-Juarez","year":"2016","unstructured":"Pineda-Juarez JA, Sanchez-Ortiz NA, Castillo-Martinez L, Orea-Tejeda A, Cervantes-Gaytan R, Keirns-Davis C, et al. Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation. Clin Nutr (Edinb, Scotl). 2016;35:41\u20137.","journal-title":"Clin Nutr (Edinb, Scotl)"},{"key":"1076_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2018.08.011","volume":"209","author":"X Du","year":"2018","unstructured":"Du X, Li Y, Wang Y, You H, Hui P, Zheng Y, et al. Increased branched-chain amino acid levels are associated with long-term adverse cardiovascular events in patients with STEMI and acute heart failure. Life Sci. 2018;209:167\u201372.","journal-title":"Life Sci"},{"key":"1076_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","volume":"25","author":"T Li","year":"2017","unstructured":"Li T, Zhang Z, Kolwicz SC Jr., Abell L, Roe ND, Kim M, et al. Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metab. 2017;25:374\u201385.","journal-title":"Cell Metab"},{"key":"1076_CR11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.cmet.2022.09.008","volume":"34","author":"D Murashige","year":"2022","unstructured":"Murashige D, Jung JW, Neinast MD, Levin MG, Chu Q, Lambert JP, et al. Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure. Cell Metab. 2022;34:1749\u201364.e7.","journal-title":"Cell Metab"},{"key":"1076_CR12","doi-asserted-by":"publisher","first-page":"e011625","DOI":"10.1161\/JAHA.118.011625","volume":"8","author":"M Chen","year":"2019","unstructured":"Chen M, Gao C, Yu J, Ren S, Wang M, Wynn RM, et al. Therapeutic effect of targeting branched-chain amino acid catabolic flux in pressure-overload induced heart failure. J Am Heart Assoc. 2019;8:e011625.","journal-title":"J Am Heart Assoc"},{"key":"1076_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00726-013-1500-6","volume":"45","author":"G Wu","year":"2013","unstructured":"Wu G. Functional amino acids in nutrition and health. Amino Acids. 2013;45:407\u201311.","journal-title":"Amino Acids"},{"key":"1076_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/HCO.0000000000000552","volume":"33","author":"DK Tobias","year":"2018","unstructured":"Tobias DK, Mora S, Verma S, Lawler PR. Altered branched chain amino acid metabolism: toward a unifying cardiometabolic hypothesis. Curr Opin Cardiol. 2018;33:558\u201364.","journal-title":"Curr Opin Cardiol"},{"key":"1076_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05362-7","volume":"9","author":"D Shao","year":"2018","unstructured":"Shao D, Villet O, Zhang Z, Choi SW, Yan J, Ritterhoff J, et al. Glucose promotes cell growth by suppressing branched-chain amino acid degradation. Nat Commun. 2018;9:2935.","journal-title":"Nat Commun"},{"key":"1076_CR16","doi-asserted-by":"publisher","first-page":"H1160","DOI":"10.1152\/ajpheart.00114.2016","volume":"311","author":"W Wang","year":"2016","unstructured":"Wang W, Zhang F, Xia Y, Zhao S, Yan W, Wang H, et al. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol. 2016;311:H1160\u2013h9.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1076_CR17","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1111\/jcmm.13759","volume":"22","author":"O Zhenyukh","year":"2018","unstructured":"Zhenyukh O, Gonz\u00e1lez-Amor M, Rodrigues-Diez RR, Esteban V, Ruiz-Ortega M, Salaices M, et al. Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation. J Cell Mol Med. 2018;22:4948\u201362.","journal-title":"J Cell Mol Med"},{"key":"1076_CR18","doi-asserted-by":"publisher","first-page":"E311","DOI":"10.1152\/ajpendo.00161.2015","volume":"309","author":"NE Sunny","year":"2015","unstructured":"Sunny NE, Kalavalapalli S, Bril F, Garrett TJ, Nautiyal M, Mathew JT, et al. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Am J Physiol-Endocrinol Metab. 2015;309:E311\u2013E9.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"1076_CR19","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.M085613","volume":"59","author":"K-Y Peng","year":"2018","unstructured":"Peng K-Y, Watt MJ, Rensen S, Greve JW, Huynh K, Jayawardana KS, et al. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. J Lipid Res. 2018;59:1977\u201386.","journal-title":"J Lipid Res"},{"key":"1076_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41586-019-1503-x","volume":"572","author":"T Yoneshiro","year":"2019","unstructured":"Yoneshiro T, Wang Q, Tajima K, Matsushita M, Maki H, Igarashi K, et al. BCAA catabolism in brown fat controls energy homeostasis through SLC25A44. Nature. 2019;572:614\u20139.","journal-title":"Nature"},{"key":"1076_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.18632\/oncotarget.15304","volume":"8","author":"K Takegoshi","year":"2017","unstructured":"Takegoshi K, Honda M, Okada H, Takabatake R, Matsuzawa-Nagata N, Campbell JS, et al. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model. Oncotarget. 2017;8:11.","journal-title":"Oncotarget"},{"key":"1076_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41387-022-00200-8","volume":"12","author":"CA Bishop","year":"2022","unstructured":"Bishop CA, Machate T, Henning T, Henkel J, P\u00fcschel G, Weber D, et al. Detrimental effects of branched-chain amino acids in glucose tolerance can be attributed to valine induced glucotoxicity in skeletal muscle. Nutr Diabetes. 2022;12:20.","journal-title":"Nutr Diabetes"},{"key":"1076_CR23","doi-asserted-by":"publisher","first-page":"101261","DOI":"10.1016\/j.molmet.2021.101261","volume":"52","author":"PJ White","year":"2021","unstructured":"White PJ, McGarrah RW, Herman MA, Bain JR, Shah SH, Newgard CB. Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Mol Metab. 2021;52:101261.","journal-title":"Mol Metab"},{"key":"1076_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db18-0927","volume":"68","author":"M Zhou","year":"2019","unstructured":"Zhou M, Shao J, Wu C-Y, Shu L, Dong W, Liu Y, et al. Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes. 2019;68:1730.","journal-title":"Diabetes"},{"key":"1076_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0892-3","volume":"18","author":"GM Uddin","year":"2019","unstructured":"Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol. 2019;18:86.","journal-title":"Cardiovasc Diabetol"},{"key":"1076_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","volume":"118","author":"C Riehle","year":"2016","unstructured":"Riehle C, Abel ED. Insulin signaling and heart failure. Circ Res. 2016;118:1151\u201369.","journal-title":"Circ Res"},{"key":"1076_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/hh1301.092687","volume":"89","author":"DS Sohal","year":"2001","unstructured":"Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible cre protein. Circ Res. 2001;89:20\u20135.","journal-title":"Circ Res"},{"key":"1076_CR28","doi-asserted-by":"publisher","first-page":"e011625","DOI":"10.1161\/JAHA.118.011625","volume":"8","author":"M Chen","year":"2019","unstructured":"Chen M, Gao C, Yu J, Ren S, Wang M, Wynn RM, et al. Therapeutic effect of targeting branched\u2010chain amino acid catabolic flux in pressure\u2010overload induced heart failure. J Am Heart Assoc. 2019;8:e011625.","journal-title":"J Am Heart Assoc"},{"key":"1076_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"1076_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1076_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3389\/fphys.2017.00853","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Dong W, Shao J, Wang Y, Zhou M, Sun H. Branched-chain amino acid negatively regulates KLF15 expression via PI3K-AKT pathway. Front Physiol. 2017;8:853.","journal-title":"Front Physiol"},{"key":"1076_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2021.08.240","volume":"175","author":"S Liu","year":"2021","unstructured":"Liu S, Li L, Lou P, Zhao M, Wang Y, Tang M, et al. Elevated branched-chain \u03b1-keto acids exacerbate macrophage oxidative stress and chronic inflammatory damage in type 2 diabetes mellitus. Free Radic Biol Med. 2021;175:141\u201354.","journal-title":"Free Radic Biol Med"},{"key":"1076_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34216-6","volume":"13","author":"MG Levin","year":"2022","unstructured":"Levin MG, Tsao NL, Singhal P, Liu C, Vy HMT, Paranjpe I, et al. Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat Commun. 2022;13:6914.","journal-title":"Nat Commun"},{"key":"1076_CR34","doi-asserted-by":"publisher","first-page":"172796","DOI":"10.1016\/j.ejphar.2019.172796","volume":"866","author":"K Lian","year":"2020","unstructured":"Lian K, Guo X, Wang Q, Liu Y, Wang R-T, Gao C, et al. PP2Cm overexpression alleviates MI\/R injury mediated by a BCAA catabolism defect and oxidative stress in diabetic mice. Eur J Pharmacol. 2020;866:172796.","journal-title":"Eur J Pharmacol"},{"key":"1076_CR35","doi-asserted-by":"publisher","first-page":"101611","DOI":"10.1016\/j.molmet.2022.101611","volume":"66","author":"E Bollinger","year":"2022","unstructured":"Bollinger E, Peloquin M, Libera J, Albuquerque B, Pashos E, Shipstone A, et al. BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice. Mol Metab. 2022;66:101611.","journal-title":"Mol Metab"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01076-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01076-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01076-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T07:03:32Z","timestamp":1688022212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01076-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1038\/s41401-023-01076-9","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Rachel J Roth Flach is a Pfizer employee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}